PRF Technologies (PRFX) Liabilities and Shareholders Equity (2019 - 2025)

PRF Technologies (PRFX) recorded quarterly Liabilities and Shareholders Equity of $12.0 million in Q4 2025, up 7.49% on a QoQ basis from $11.2 million in Q2 2025, and up 165.15% year-over-year from $4.5 million in Q4 2024.

PRF Technologies (PRFX) Liabilities and Shareholders Equity (2019 - 2025) Analysis & Trends

PRF Technologies has disclosed Liabilities and Shareholders Equity across 7 years of filings, most recently posting $12.0 million for Q4 2025.

  • Quarterly Liabilities and Shareholders Equity rose 165.15% year-over-year to $12.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $30.8 million (up 129.96% YoY) and the FY2025 annual result came in at $12.0 million, up 165.15% from the prior year.
  • Liabilities and Shareholders Equity climbed to $12.0 million in Q4 2025, from $11.2 million in the prior quarter.
  • Over five years, Liabilities and Shareholders Equity peaked at $21.4 million in Q1 2021 and troughed at $389000.0 in Q4 2023.
  • A 5-year average of $12.2 million and a median of $12.0 million in 2025 frame the typical range for Liabilities and Shareholders Equity.
  • Annual changes were most pronounced in 2021 — Liabilities and Shareholders Equity surged 2267.3% — and 2023, when it slumped 96.84%.
  • Tracing PRFX's Liabilities and Shareholders Equity over 5 years: stood at $19.1 million in 2021, then tumbled by 35.36% to $12.3 million in 2022, then sank by 96.84% to $389000.0 in 2023, then surged by 1063.24% to $4.5 million in 2024, then jumped by 165.15% to $12.0 million in 2025.
  • Business Quant data shows PRFX's Liabilities and Shareholders Equity at $12.0 million in Q4 2025, $11.2 million in Q2 2025, and $4.5 million in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn 40.04 Bn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn 15.15 Bn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn 6.71 Bn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn 555.95 Mn
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn 4.91 Bn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn 13.22 Bn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn 4.26 Bn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn 2.27 Bn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn 2.35 Bn
10 PRF Technologies 933,081.16 -2.46 Mn - 12.00 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 12.00 Mn
Jun 30, 2025 11.16 Mn
Dec 31, 2024 4.53 Mn
Jun 30, 2024 3.11 Mn
Mar 31, 2024 5.37 Mn
Dec 31, 2023 389,000.00
Sep 30, 2023 10.89 Mn
Jun 30, 2023 8.32 Mn
Mar 31, 2023 10.42 Mn
Dec 31, 2022 12.33 Mn
Sep 30, 2022 14.85 Mn
Jun 30, 2022 15.99 Mn
Mar 31, 2022 17.71 Mn
Dec 31, 2021 19.07 Mn
Sep 30, 2021 20.34 Mn
Jun 30, 2021 19.84 Mn
Mar 31, 2021 21.35 Mn
Dec 31, 2020 17.80 Mn
Jun 30, 2020 838,000.00
Dec 31, 2019 1.16 Mn